ARTICLE | Strategy

Novo gets serious about AI-guided drug design

How Novo is using AI and its restructured research units to drive innovation

December 8, 2018 1:21 AM UTC

Novo Nordisk A/S is fashioning its R&D makeover to integrate artificial intelligence across its drug discovery and development process, after a pilot program delivered the cost and time savings the pharma was looking for.

In 2019, Novo will redirect the budget for new lab space and equipment into computers and software. In September, the company trimmed its R&D workforce by 400 heads, primarily by slimming down its medicinal chemistry teams. It will retain chemists who work in data science. ...

BCIQ Company Profiles

Novo Nordisk A/S